Genomma Lab stock: On Frankfurt, Genomma Lab stock gains 6.15 percent

Published on 10/21/2026 at 17:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue rose 4.93 percent to MXN 4.40 billion. Genomma Lab stock costs EUR 0.69 on October 21, 2026, up 6.15 percent versus Frankfurt close.

Price and earnings facts

Genomma Lab stock gained 6.15 percent versus the Frankfurt close of October 16, 2026.
Second-quarter revenue rose 4.93 percent to MXN 4.40 billion.
Genomma Lab stock costs EUR 0.69 at Lang & Schwarz on October 21, 2026 at 5:38 p.m. CEST, 6.15 percent above the Frankfurt close of October 16, 2026.
Third-quarter results are scheduled for October 22, 2026.

Genomma Lab, MX01LA010006, Illustration mit AI erstellt.

Genomma Lab (ISIN MX01LA010006) increased second-quarter revenue 4.93 percent to MXN 4.40 billion, while net income fell 24.29 percent to MXN 374.49 million from the previous quarter. Investing.com attributes the latest-quarter figures to Genomma Lab. The stock was trading at EUR 0.69 at Lang & Schwarz on October 21, 2026 at 5:38 p.m. CEST, 6.15 percent above the Frankfurt close of October 16, 2026 at EUR 0.65.

Revenue rose as profit declined

The second-quarter revenue increase came with a sharper earnings setback. Net income declined from MXN 494.65 million in the previous quarter to MXN 374.49 million, while reported earnings per share stood at MXN 0.37 against MXN 0.51 in the first quarter, according to Investing.com.

Stock stays below its yearly high

Genomma Lab traded at MXN 14.19 on BMV on October 21, 2026, compared with a 52-week range of MXN 12.22 to MXN 19.48 reported for the Mexican listing. The current BMV level is 27.15 percent below the 52-week high. The company has a market capitalization of MXN 13.9 billion, a price-to-earnings ratio of 8.60 and a dividend yield of 6.00 percent as of October 21, 2026.

Results date adds a near-term marker

Genomma Lab is scheduled to hold its third-quarter 2026 earnings call on October 22, 2026, according to Yahoo Finance. The same page lists six analysts for the 2026 estimate and a revenue range of MXN 16.88 billion to MXN 19.98 billion. The company had announced an Investor Day for December 3, 2026, in New York on October 15, 2026, with artificial intelligence demonstrations and operational updates, PR Newswire reported.

Price move sets the daily tone

For investors, the contrast is clear: revenue advanced in the second quarter, but net income and earnings per share moved lower. The euro quotation is also well below the Mexican listing's 52-week high, leaving the October 22 results update as the next dated test for the stock.

Genomma Lab stock price and outlook

Genomma Lab was trading at EUR 0.69 at Lang & Schwarz on October 21, 2026 at 5:38 p.m. CEST, 6.15 percent above the Frankfurt close of October 16, 2026 at EUR 0.65. The further course of trading is shown by the continuously updated real-time quote of Genomma Lab stock.